Latest Neuroblastoma Stories
To view the Social Media Release, click here: http://smr.newswire.ca/en/canadian-cancer-society/when-cancer-strikes-the-most-vulnerable TORONTO, April 27 /PRNewswire/ - A new Canadian Cancer Society-funded study will investigate the genetic puzzle of a devastating nervous system cancer that strikes infants, and identify potential new treatments for the disease.
BUFFALO, N.Y., April 19, 2011 /PRNewswire/ -- Today, H.
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma.
BUFFALO, N.Y., Jan.
Pediatric cancer researchers have identified variations in a gene as important contributors to neuroblastoma, the most common solid cancer of early childhood.
Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy, with an annual incidence of about 650 new cases per year in the United States.
Black, Asian, and Native American children are more likely than white and Hispanic children to die after being treated for neuroblastoma.
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy.
CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
Chemotherapy is not as beneficial to young children when it comes to fighting certain forms of cancer as previously thought.